Mohsen Ghanbari

Mohsen Ghanbari is an Associate Professor in the Department of Epidemiology at Erasmus MC, Rotterdam. He leads the 'Molecular & Systems Epidemiology' research line as Principal Investigator, overseeing a multidisciplinary team of MSc students, PhD candidates, postdoctoral researchers, and lab technicians. His work is deeply embedded in large-scale population studies, including the Rotterdam Study and the Erasmus Rucphen Family (ERF) study.

Research Interests: Dr. Ghanbari’s research focuses on uncovering genetic determinants and identifying novel biomarkers for complex age-related diseases such as Alzheimer’s disease, cardiometabolic disorders, and fatty liver disease. He integrates multi-omics data—genomics, epigenomics, metabolomics, and transcriptomics—using advanced analytical and molecular techniques. His work aims to elucidate disease mechanisms and improve early diagnosis and risk stratification.

Recent Research Trends: His most recent publications (2025) highlight a strong focus on aging, biomarker discovery, and population genomics. Articles span diverse areas including metabolomics of adipose tissue, plasma microRNA signatures in aging, Y-chromosome variation in forensics, environmental-genetic interactions in mortality, and non-coding RNA in eye disorders. These reflect a cohesive trajectory toward systems-level understanding of aging and complex diseases.

Scientific Recognition: His work has been published in high-impact journals such as Nature Medicine, Genome Medicine, and Human Genetics. His research has been widely disseminated, with mentions in 325 news outlets, over 1,000 posts on X (formerly Twitter), and engagement across Facebook, Bluesky, and Reddit, indicating significant academic and public impact.

Teaching and Supervision: Dr. Ghanbari is actively involved in academic education, coordinating multiple courses through the Netherlands Institute for Health Sciences (NIHES) at Erasmus MC Graduate School. He supervises MSc and PhD students, though specific names are not listed in the provided text. He also manages omics data for the Rotterdam Study and leads the ERF study.

Collaborations and Infrastructure: He participates in numerous international multicenter consortia focused on population omics and age-related diseases, reflecting a strong collaborative network. His lab functions as a hub for molecular and systems epidemiology, integrating bioinformatics with experimental validation.